In the last 12 months, insiders at CervoMed Inc. ($CRVO) filed 57 transactions with the SEC: 20 open-market purchases totaling $791,695 and 1 sales totaling $0. Net insider sentiment: net buying.
CervoMed Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- ALAM JOHN J (CEO & President) — 11 transactions totaling $282,652
- Gregoire Sylvie (Director) — 11 transactions totaling $282,652
- Winton Matthew (Chief Commercial and Business) — 5 transactions totaling $117,130
- ELDER WILLIAM ROBERT (CFO, GC & Secretary) — 5 transactions totaling $91,101
- ELDER WILLIAM ROBERT (CFO & GC) — 2 transactions totaling $18,160
View all SEC Filings for CervoMed Inc. (CRVO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Gregoire Sylvie | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 9,252,719 | 9999.99% | 0.81% |
| Feb. 11, 2026 | Blackburn Kelly | EVP, Clinical Development | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 9,252,719 | 9999.99% | 0.32% |
| Feb. 11, 2026 | Winton Matthew | Chief Commercial and Business | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 9,252,719 | 9999.99% | 0.32% |
| Feb. 11, 2026 | ALAM JOHN J | CEO & President | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 9,252,719 | 9999.99% | 0.81% |
| Feb. 11, 2026 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 9,252,719 | 9999.99% | 0.32% |
| Feb. 11, 2026 | De Rosch Mark | EVP, RA and GA and PgM | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 9,252,719 | 9999.99% | 0.32% |
| Oct. 27, 2025 | Quigley David | Director | A | Stock Option (Right to Buy) | 16200 | $0.00 | 16,200.0000 | 8,702,719 | 9999.99% | 0.19% |
| Nov. 18, 2025 | Winton Matthew | Chief Commercial and Business | P | Common Stock | 1500 | $7.95 | 15,000.0000 | 9,252,719 | 11.11% | 0.02% |
| Nov. 17, 2025 | ALAM JOHN J | CEO & President | P | Common Stock | 10793 | $8.46 | 1,496,578.0000 | 9,252,719 | 0.73% | 0.12% |
| Nov. 17, 2025 | ALAM JOHN J | CEO & President | P | Common Stock | 10807 | $8.46 | 1,496,578.0000 | 9,252,719 | 0.73% | 0.12% |
| Nov. 18, 2025 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | P | Common Stock | 2500 | $8.32 | 12,500.0000 | 9,252,719 | 25.00% | 0.03% |
| Nov. 17, 2025 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | P | Common Stock | 1000 | $8.45 | 10,000.0000 | 9,252,719 | 11.11% | 0.01% |
| Nov. 17, 2025 | Gregoire Sylvie | Director | P | Common Stock | 10807 | $8.46 | 1,496,578.0000 | 9,252,719 | 0.73% | 0.12% |
| Nov. 17, 2025 | Gregoire Sylvie | Director | P | Common Stock | 10793 | $8.46 | 1,496,578.0000 | 9,252,719 | 0.73% | 0.12% |
| Nov. 17, 2025 | Winton Matthew | Chief Commercial and Business | P | Common Stock | 3500 | $8.43 | 13,500.0000 | 9,252,719 | 35.00% | 0.04% |
| Nov. 14, 2025 | Winton Matthew | Chief Commercial and Business | P | Common Stock | 10000 | $7.57 | 10,000.0000 | 9,252,719 | 9999.99% | 0.11% |
| Nov. 14, 2025 | ALAM JOHN J | CEO & President | P | Common Stock | 1707 | $7.57 | 1,474,978.0000 | 9,252,719 | 0.12% | 0.02% |
| Nov. 14, 2025 | ALAM JOHN J | CEO & President | P | Common Stock | 1693 | $7.55 | 1,474,978.0000 | 9,252,719 | 0.11% | 0.02% |
| Nov. 13, 2025 | ALAM JOHN J | CEO & President | P | Common Stock | 4447 | $7.51 | 1,473,285.0000 | 9,252,719 | 0.30% | 0.05% |
| Nov. 14, 2025 | Gregoire Sylvie | Director | P | Common Stock | 1693 | $7.55 | 1,474,978.0000 | 9,252,719 | 0.11% | 0.02% |
| Nov. 14, 2025 | Gregoire Sylvie | Director | P | Common Stock | 1707 | $7.57 | 1,474,978.0000 | 9,252,719 | 0.12% | 0.02% |
| Nov. 13, 2025 | Gregoire Sylvie | Director | P | Common Stock | 4447 | $7.51 | 1,473,271.0000 | 9,252,719 | 0.30% | 0.05% |
| Nov. 12, 2025 | Gregoire Sylvie | Director | P | Common Stock | 5553 | $7.35 | 1,467,131.0000 | 9,252,719 | 0.38% | 0.06% |
| Nov. 12, 2025 | ALAM JOHN J | CEO & President | P | Common Stock | 5553 | $7.35 | 1,467,131.0000 | 9,252,719 | 0.38% | 0.06% |
| Nov. 12, 2025 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | P | Common Stock | 3500 | $7.44 | 9,000.0000 | 9,252,719 | 63.64% | 0.04% |
| Oct. 6, 2025 | Winton Matthew | Chief Commercial and Business | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,702,719 | 9999.99% | 0.86% |
| June 23, 2025 | Poulton Jeffrey V. | Director | A | Stock Option (Right to Buy) | 8100 | $0.00 | 8,100.0000 | 8,702,719 | 9999.99% | 0.09% |
| June 23, 2025 | Sabbagh Marwan | Director | A | Stock Option (Right to Buy) | 8100 | $0.00 | 8,100.0000 | 8,702,719 | 9999.99% | 0.09% |
| June 23, 2025 | BOGER JOSHUA S | Director | A | Stock Option (Right to Buy) | 8100 | $0.00 | 8,100.0000 | 8,702,719 | 9999.99% | 0.09% |
| June 23, 2025 | ZAVRL FRANK | Director | A | Stock Option (Right to Buy) | 8100 | $0.00 | 8,100.0000 | 8,702,719 | 9999.99% | 0.09% |
| June 23, 2025 | ALAM JOHN J | CEO & President | A | Stock Option (Right to Buy) | 8100 | $0.00 | 8,100.0000 | 8,702,719 | 9999.99% | 0.09% |
| June 23, 2025 | Hollingsworth Jane H | Director | A | Stock Option (Right to Buy) | 8100 | $0.00 | 8,100.0000 | 8,702,719 | 9999.99% | 0.09% |
| June 23, 2025 | Gregoire Sylvie | Director | A | Stock Option (Right to Buy) | 8100 | $0.00 | 8,100.0000 | 8,702,719 | 9999.99% | 0.09% |
| May 14, 2025 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | P | Common Stock | 4233 | $8.46 | 5,500.0000 | 8,702,719 | 334.10% | 0.05% |
| Feb. 4, 2025 | Gregoire Sylvie | Director | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2025 | ELDER WILLIAM ROBERT | CFO & GC | A | Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2025 | Cobuzzi Robert Joseph Jr. | Chief Operating Officer | A | Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2025 | Blackburn Kelly | SVP, Clinical Development | A | Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2025 | ALAM JOHN J | CEO & President | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 27, 2024 | ELDER WILLIAM ROBERT | CFO & GC | P | Common Stock | 1000 | $18.16 | 1,267.0000 | 0 | 374.53% | 0.00% |
| June 14, 2024 | Sabbagh Marwan | Director | A | Stock Option (Right to Buy) | 5750 | $0.00 | 5,750.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | ZAVRL FRANK | Director | A | Stock Option (Right to Buy) | 5750 | $0.00 | 5,750.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Poulton Jeffrey V. | Director | A | Stock Option (Right to Buy) | 5750 | $0.00 | 5,750.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Hollingsworth Jane H | Director | A | Stock Option (Right to Buy) | 5750 | $0.00 | 5,750.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Gregoire Sylvie | Director | A | Stock Option (Right to Buy) | 5750 | $0.00 | 5,750.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | BOGER JOSHUA S | Director | A | Stock Option (Right to Buy) | 5750 | $0.00 | 5,750.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | ALAM JOHN J | CEO & President | A | Stock Option (Right to Buy) | 5750 | $0.00 | 5,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | BOGER JOSHUA S | Director | X | Common Stock | 495995 | $0.00 | 1,057,304.0000 | 0 | 88.36% | 0.00% |
| Feb. 26, 2024 | BOGER JOSHUA S | Director | X | Pre-Funded Common Stock Purchase Warrant | 495995 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 26, 2024 | BOGER JOSHUA S | Director | S | Common Stock | 36 | $0.00 | 1,057,268.0000 | 0 | 0.00% | 0.00% |
| Feb. 12, 2024 | BOGER JOSHUA S | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Cobuzzi Robert Joseph Jr. | Chief Operating Officer | A | Stock Option (Right to Buy) | 55721 | $0.00 | 55,721.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Blackburn Kelly | SVP, Clinical Development | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | ALAM JOHN J | CEO & President | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | TANNER JOHN WILLIAM | Chief Financial Officer | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | ELDER WILLIAM ROBERT | GC & Secretary | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Gregoire Sylvie | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 0 | 9999.99% | 0.00% |